Key regions: Brazil, India, Australia, United States, United Kingdom
As the world is facing the COVID-19 pandemic, the demand for antiviral drugs has increased significantly. In Armenia, the antiviral drugs market has also experienced growth in recent years.
Customer preferences: Armenia has a high prevalence of infectious diseases, including hepatitis, HIV, and tuberculosis. Therefore, the demand for antiviral drugs has been increasing in the country. Additionally, the COVID-19 pandemic has also contributed to the growth of the antiviral drugs market in Armenia.
Trends in the market: The antiviral drugs market in Armenia is mainly driven by the demand for drugs that treat hepatitis B and C, HIV, and influenza. The market has seen a shift towards generic drugs due to their lower cost compared to branded drugs. Moreover, the government has been taking steps to increase access to affordable antiviral drugs, which has also contributed to the growth of the market.
Local special circumstances: Armenia has a relatively small population, which limits the size of the antiviral drugs market. However, the country has a well-developed healthcare system, which has helped to increase access to antiviral drugs. Additionally, the government has implemented policies to increase access to affordable drugs, which has helped to increase demand for antiviral drugs.
Underlying macroeconomic factors: Armenia has a developing economy, which has been growing in recent years. The country has a strong pharmaceutical industry, which has helped to increase the availability of antiviral drugs. Moreover, the government has been investing in the healthcare sector, which has helped to increase access to healthcare services, including antiviral drugs. However, the country still faces challenges such as a high poverty rate and a lack of resources, which can limit access to healthcare services for some parts of the population.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
